Burning Mouth Syndrome clinical trials
The registry lists 47 studies for Burning Mouth Syndrome across more than 10 countries. 6 are recruiting or about to start. 39 of them are mainly about Burning Mouth Syndrome (how this is decided). Per ClinicalTrials.gov, last updated 2026-08-17.
Get an email when these change. Save the Burning Mouth Syndrome studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
University of Zagreb (5) · Universidad de Murcia (5) · National Institute of Dental and Craniofacial Research (NIDCR) (2) · Lu Jiang (2) · Malmö University (2) · University of California, San Francisco (2) · University of Catania (2) · Presidio Ospedaliero Garibaldi-Centro (1)
What is being tested here
Drugs under test in Burning Mouth Syndrome studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Vortioxetine | 1 | 1 | 1 |
| Clonazepam | 0 | 0 | 4 |
| Melatonin | 0 | 0 | 2 |
| Thioctic Acid | 0 | 0 | 1 |
| Acetylcysteine | 0 | 0 | 1 |
| Caffeine | 0 | 0 | 1 |
| Diazepam | 0 | 0 | 1 |
| Botulinum toxin type A | 0 | 0 | 1 |
| Thalidomide | 0 | 0 | 1 |
| Nalbuphine | 0 | 0 | 1 |
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3
- Nov 2026Burning Mouth Syndrome: Effects of Occlusal Splint Therapy · Malmö University
- Dec 2026Reducing Patient Memory Recall in the Burning Mouth Patient Population · University of Pennsylvania
- Nov 2027Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led Model · University of Fujairah
Who these studies take
Of the 4 Burning Mouth Syndrome studies recruiting now, 3 (75%) set no upper age limit and 0 (0%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 4 (100%) | 4 (100%) |
| 30 | 4 (100%) | 4 (100%) |
| 40 | 4 (100%) | 4 (100%) |
| 50 | 4 (100%) | 4 (100%) |
| 65 | 4 (100%) | 4 (100%) |
| 75 | 4 (100%) | 4 (100%) |
| 85 | 4 (100%) | 4 (100%) |
Across all 47 studies, recruiting or not: 23% stop at 75 or younger and 4% at 65; 9% take children; 17% are for women only and 0% for men only; 36% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Burning Mouth Syndrome studies take
Of 15 interventional studies with no phase under Burning Mouth Syndrome, half reached primary completion within 14 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 14 mo6–33 · 15 studies | — | — |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
Studies
Recruiting first, then most recently updated. Showing 47 of 47. search them.
- Improving Prescribing Quality for Oral Mucosal Disorders Using a Pharmacist-Led ModelNot yet recruitingNCT07721090Not applicable
- MucoLock™ for Treatment of StomatitisRecruitingNCT07506018Not applicable1 country
- Reducing Patient Memory Recall in the Burning Mouth Patient PopulationRecruitingNCT058196971 country
- Burning Mouth Syndrome: Effects of Occlusal Splint TherapyNot yet recruitingNCT07344909Not applicable1 country
- Burning Mouth Syndrome: Symptoms and ManagementRecruitingNCT07016555Early Phase 11 country
- Comparison of Vortioxetine Versus Other Antidepressants With Pregabalin Augmentation in Burning Mouth SyndromeRecruitingNCT06025474Phase 31 country
- Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth SyndromeCompletedNCT06040190Phase 41 country
- Theravex® for Burning Mouth SyndromeCompletedNCT07564843Not applicable1 country
- Photobiomodulation Therapy vs. Alpha-Lipoic Acid in Burning Mouth Syndrome TreatmentActive, not recruitingNCT07381361Not applicable1 country
- Topical Amitriptyline 1% Gel for the Treatment of Burning Mouth SyndromeCompletedNCT072141811 country
- The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth SyndromeCompletedNCT05309070Not applicable1 country
- Inflammatory Markers in Saliva of Patients With Burning Mouth SyndromeCompletedNCT06217731Not applicable1 country
- Comparison Between Two Treatments for Burning MouthCompletedNCT05816200Not applicable1 country
- Effect to the Photobiomodulation in the Burning Mouth SyndromeCompletedNCT05871580Not applicable1 country
- Caffeine vs. ALA in BMS Treatment. (BMS: Burning Mouth Syndrome. ALA: Alpha-Lipoic Acid.)CompletedNCT06195137Not applicable1 country
- Impact of Diazepam 1% Oral Gel Efficacy in Burning Mouth SyndromeCompletedNCT05872789Not applicable1 country
- Impact of Alpha Lipoic Acid Efficacy in Burning Mouth SyndromeStatus unknownNCT05729529Not applicable1 country
- Thermography and Burning Mouth SyndromeCompletedNCT053992381 country
- Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth SyndromeCompletedNCT053096811 country
- Burning Mouth Syndrome Mouth Guard Prospective StudyCompletedNCT04203134Not applicable1 country
- Burning Mouth Syndrome - New Diagnostic Criteria and TreatmentStatus unknownNCT05059418Not applicable
- Evaluation of the Effectiveness of the Selected Method of Treatment of Primary Burning Mouth SyndromeCompletedNCT04884503Phase 21 country
- Head Yuanshi Dian Therapy in Burning Mouth SyndromeStatus unknownNCT04481841Early Phase 11 country
- Identification of Pathophysiological Pathways and Therapeutic Targets in Primary Stomatodynia by Salivary MetabolomicsCompletedNCT047041281 country
- Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth SyndromeCompletedNCT045359731 country
- Therapeutic Options for Treatment of Burning Mouth SyndromeCompletedNCT04475614Not applicable1 country
- Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western MedicineStatus unknownNCT04189367Phase 31 country
- Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth SymdromeStatus unknownNCT04313907Phase 41 country
- Effects of Photobiomodulation in Burning Mouth SyndromeCompletedNCT04034849Not applicable1 country
- The Efficacy of Melatonin in the Burning Mouth SyndromeStatus unknownNCT03788733Not applicable1 country
- Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth SyndromeWithdrawnNCT02690844Phase 4
- Assessment of Peripheral GABA Receptors for Local Pain ReliefStatus unknownNCT02928328Not applicable1 country
- Study Evaluating the Laser Diode Effect Burning Mouth SyndromeCompletedNCT02757612Not applicable1 country
- Neurogenic Mechanisms in Burning Mouth SyndromeCompletedNCT00875537Not applicable1 country
- Botulinum Toxin in Burning Mouth SyndromeCompletedNCT02964728Phase 2
- Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial PainTerminatedNCT00716807Not applicable1 country
- Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN)CompletedNCT02686359Not applicable
- HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth SyndromeStatus unknownNCT01931293Not applicable1 country
- Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain DisordersCompletedNCT00374673Phase 31 country
- Efficacy of Melatonin in Burning Mouth Syndrome (BMS)CompletedNCT02580734Not applicable
- Acupuncture Versus Clonazepam in Burning Mouth SyndromeCompletedNCT02382029Early Phase 1
- Effect of Gluten Free Diet in Patients With Burning Mouth SyndromeStatus unknownNCT01867151Not applicable1 country
- The Role of Xerostomia in Burning Mouth Syndrome: Case - Control StudyCompletedNCT01754740Not applicable1 country
- Burning Mouth Disorder (BMD) - A Neuropathic Pain DisorderStatus unknownNCT005043871 country
- A Study of the Association of Sleep Dysfunction and Burning Mouth SyndromeCompletedNCT008625761 country
- Evaluation and Treatment of Oral Soft Tissue DiseasesCompletedNCT00001601Not applicable1 country
- Thalidomide to Treat Oral Lesions in HIV-Infected PatientsCompletedNCT00001524Phase 21 country